Crovalimab
id:
crovalimab-179-17165055
title:
Crovalimab
text:
Crovalimab, sold under the brand name Piasky, is a monoclonal antibody used for the treatment of people with paroxysmal nocturnal hemoglobinuria. It is a complement component 5 (C5) inhibitor. Crovalimab was approved for use in China in February 2024, in Japan in April 2024, in the United States in June 2024 and in the European Union in August 2024. It was developed and is marketed by Roche/Genentech.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Crovalimab
date created:
2023-11-25T08:23:17Z
date modified:
2024-09-05T05:38:29Z
main entity:
{"identifier":"Q123574195","url":"https://www.wikidata.org/entity/Q123574195"}
image:
fields total:
13
integrity:
15